GC-MS AND IN VITRO ANTIBACTERIAL EVALUATION OF Indigofera arrecta ROOT EXTRACTS AGAINST MULTIDRUG-RESISTANT (MDR) Staphylococcus aureus CLINICAL ISOLATES
SAMIRA GARBA1, IBRAHIM YAKUBU KOKARI1, DANMALA M. UMAR HABIB2, MUHAMMAD MUHSIN FATHUDDIN3, JOHN SOLOMON OBIDAH4, AYOKUNNUMI FUNKE OBAJULUWA5, MOJIRAYO TITILAYO DUROWAIYE6
1. Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, Ahmadu Bello University, Zaria, Nigeria.
2. Department of Pharmacognosy and Drug Development, Faculty of Pharmaceutical Sciences, Ahmadu Bello University, Zaria, Nigeria.
3. Department of Microbiology, Faculty of Life Sciences, Ahmadu Bello University, Zaria, Nigeria.
4. Department of Microbiology, Faculty of Life Sciences, Modibbo Adama University, Yola, Adamawa State, Nigeria.
5. Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmacy, Kaduna State University, Kaduna, Nigeria.
6. Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Nigeria.
Afr. J Pharm Res Dev; Volume 18(2): 713-725; 2026
ABSTRACT
Indigofera arrecta has a long history in traditional medicine within the Zaria metropolis for managing bacterial infections. This study sought to identify the antibacterial efficacy and bioactive constituents responsible for combating multidrug-resistant Staphylococcus aureus clinical isolates. The roots of I. arrecta were extracted via cold maceration and subsequent solvent fractionation techniques. The crude extract and its fractions were evaluated against MDR S. aureus clinical isolates from blood, urine, and wounds utilising agar well diffusion, broth dilution, and agar dilution techniques. Phytochemical analyses were conducted. Bioactive substances were isolated via column chromatography and direct bioautography TLC, and their identification was accomplished through GC-MS analysis. An acute toxicity assessment was performed per the recommendations of the Organization for Economic Co-operation and Development (OECD). The mechanism of action was assessed using in vitro microbiological methods. The root extract and its fractions revealed the presence of cardiac glycosides, saponins, flavonoids, terpenoids, phenols, tannins, and alkaloids. All exhibited activity at different concentrations, with ethyl acetate the most active at a minimum inhibitory dosage of 25.00±0.58 mg/mL. The most activity was noted in Fractions 12 and 60. The bioautography plate indicated Rf 0.13 as the active region in Fraction 12. GC-MS analysis identified 14 chemicals, predominantly fatty aldehydes. Majority of compounds were recognised for their antibacterial activities. Included are 13-octadecenal, 8-hexadecenal, 2-tridecenal, Quinuclidine alkaloid, (E)-1,2-Benzenedicarboxylic acid, Behenic alcohol, Tetradecyl Oxirane, and Oleic Acid. The active portion enhanced cell membrane permeability and induce the leaking of cell contents. Acute toxicity experiments demonstrated that the active extract and its fractions did not cause mortality in Wistar rats. The root extract and fractions of I. arrecta showed substantial efficacy against multidrug-resistant S. aureus clinical isolates.
Keywords: MDR Staphylococcus aureus, Indigofera arrecta, Bioautography, GC-MS.
Email of correspondence: [email protected]
https://doi.org/10.59493/ajopred/2026.2.2 ISSN: 0794-800X (print); 1596-2431 (online)
“`
